| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 1P48L61KM0 |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| AGONIST | Tumor necrosis factor receptor superfamily member 10B agonist | PubMed |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Non-Small-Cell Lung | 1 | D002289 | ClinicalTrials |
| Hodgkin Disease | 1 | D006689 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
| Pancreatic Neoplasms | 1 | D010190 | ClinicalTrials |
| Lymphoma, Mantle-Cell | 1 | D020522 | ClinicalTrials |
| Sarcoma | 1 | D012509 | ClinicalTrials |
| Fallopian Tube Neoplasms | 1 | D005185 | ClinicalTrials |
| Ovarian Neoplasms | 1 | D010051 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| CAS NUMBER | 896731-82-1 |
| ChEMBL | CHEMBL1743003 |
| FDA SRS | 1P48L61KM0 |
CONTENTS